LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.01 | 17.25 | 913 | 389 | 2.3440 | 1.4171 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 7.01 | 17.25 | 868 | 389 | 2.2285 | 1.3901 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.98 | 17.25 | 933 | 445 | 2.0963 | 1.3420 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.98 | 17.25 | 7 | 445 | 0.0157 | -0.1750 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 8.98 | 17.25 | 902 | 445 | 2.0266 | 1.3252 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.95 | 17.25 | 1 | 471 | 0.0021 | -0.4494 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.95 | 17.25 | 958 | 471 | 2.0315 | 1.3202 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.95 | 17.25 | 15 | 471 | 0.0318 | -0.0289 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 10.95 | 17.25 | 924 | 471 | 1.9594 | 1.3027 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.91 | 17.25 | 1 | 494 | 0.0020 | -0.4446 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.91 | 17.25 | 962 | 494 | 1.9440 | 1.2943 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.91 | 17.25 | 15 | 494 | 0.0303 | -0.0285 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 12.91 | 17.25 | 939 | 494 | 1.8975 | 1.2829 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.88 | 17.25 | 963 | 534 | 1.8019 | 1.2525 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.88 | 17.25 | 11 | 534 | 0.0206 | -0.0869 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 14.88 | 17.25 | 962 | 534 | 1.8001 | 1.2520 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.85 | 17.25 | 971 | 655 | 1.4812 | 1.1554 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.85 | 17.25 | 84 | 655 | 0.1281 | 0.3521 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 16.85 | 17.25 | 972 | 655 | 1.4827 | 1.1559 | MN20160310_N02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 18.82 | 17.25 | 992 | 800 | 1.2392 | 1.0790 | MN20160310_N02 | J14 |